中南大学学报(医学版)Pub Date : 2025-03-28DOI: 10.11817/j.issn.1672-7347.2025.240211
Zhen Tang, Lingxue Hu, Yu Rao, Ruijian Ren, Shu Ding
{"title":"Diagnostic value of reflectance confocal microscopy in papular dermatoses of the female vulva.","authors":"Zhen Tang, Lingxue Hu, Yu Rao, Ruijian Ren, Shu Ding","doi":"10.11817/j.issn.1672-7347.2025.240211","DOIUrl":"https://doi.org/10.11817/j.issn.1672-7347.2025.240211","url":null,"abstract":"<p><strong>Objectives: </strong>Papular dermatoses commonly affecting the female vulva, such as molluscum contagiosum, syringoma, lymphangioma, folliculitis, verruca vulgaris, ectopic sebaceous glands, and bowenoid papulosis, often present with similar clinical appearances and are frequently misdiagnosed. This study aims to explore the clinical diagnostic value of reflectance confocal microscopy (RCM) in differentiating these conditions.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on RCM imaging and histopathological findings from lesion sites in 172 female patients with vulval papular dermatoses. RCM characteristics confirmed by biopsy were summarized and diagnostic clues were explored.</p><p><strong>Results: </strong>RCM diagnosis was consistent with histopathological diagnosis in 147 out of 172 cases (85.47%). Molluscum contagiosum, syringoma, lymphangioma, and folliculitis all exhibited cystic-like structures under RCM, differing in the location of the structures, wall characteristics, internal contents, and reflectivity. Verruca vulgaris, ectopic sebaceous glands, and bowenoid papulosis lacked such structures. Verruca vulgaris showed distinctive low-refractive vacuolated cells in the spinous layer; bowenoid papulosis exhibited mild cytologic atypia in the spinous layer; ectopic sebaceous glands were characterized by moderately to low-refractive, fish roe-like sebaceous lobules within the dermis.</p><p><strong>Conclusions: </strong>RCM enables noninvasive, real-time, and dynamic visualization of key diagnostic and differential features of common vulvar papular dermatoses in women, offering high diagnostic value.</p>","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"50 3","pages":"366-372"},"PeriodicalIF":0.0,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中南大学学报(医学版)Pub Date : 2025-03-28DOI: 10.11817/j.issn.1672-7347.2025.240667
Hongjin Guan, Zhongling Luo, Yehong Kuang, Yi Xiao, Minxue Shen
{"title":"External stigma in patients with visible skin diseases: A qualitative study.","authors":"Hongjin Guan, Zhongling Luo, Yehong Kuang, Yi Xiao, Minxue Shen","doi":"10.11817/j.issn.1672-7347.2025.240667","DOIUrl":"https://doi.org/10.11817/j.issn.1672-7347.2025.240667","url":null,"abstract":"<p><strong>Objectives: </strong>Most dermatological conditions fall under visible skin diseases (VSDs), where lesions are exposed and readily seen, increasing patients' risk of experiencing external stigma from the public and specific professional groups (e.g., service providers). This stigma imposes psychological and social burdens that far exceed the psychological symptoms of the disease. To date, no systematic research has been conducted in China specifically on the external stigma associated with VSDs. Taking psoriasis, vitiligo, and acne as representative conditions, this study aims to explore the external stigma experienced by VSD patients across various social settings and to provide a scientific foundation for the development of measurement tools, quantitative research, and targeted interventions.</p><p><strong>Methods: </strong>A purposive sample of 23 outpatients diagnosed with psoriasis, acne, or vitiligo was recruited from the Xiangya Hospital Dermatology Clinic of Central South University between December 2023 and July 2024. In-depth qualitative interviews were conducted. Data were analyzed using Mayring's qualitative content analysis and thematic analysis. Reporting followed the Consolidated Criteria for Reporting Qualitative Research guidelines. The interviews focused on the experience of external stigma across different social settings.</p><p><strong>Results: </strong>Patients with VSDs reported experiencing external stigma in various contexts including family, community, recreational service venues, healthcare institutions, and others. The main motivation behind stigmatizing behaviors was disease avoidance (e.g., fear of contagion, aversion, social distancing). Stigmatization in school settings was also reported by patients with all 3 types of VSDs. Psoriasis patients reported stigma across all examined scenarios, while vitiligo and acne patients reported stigma in only some contexts.</p><p><strong>Conclusions: </strong>Patients with VSDs experience significant external stigma, with psoriasis patients facing a higher burden compared to those with vitiligo or acne. The predominant stigma-driving factor is the public's desire to avoid disease, which underscores the need for public education to correct misconceptions about VSDs. External stigma from family, school, social networks, healthcare providers, and structural stigma should be the focus of policy and intervention efforts aimed at protecting the rights and well-being of patients with VSDs.</p>","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"50 3","pages":"373-381"},"PeriodicalIF":0.0,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中南大学学报(医学版)Pub Date : 2025-03-28DOI: 10.11817/j.issn.1672-7347.2025.240075
Yuming Xie, Yue Hu, Junke Huang, Juan Liu, Qing Zhang
{"title":"Research progress in the role of ultraviolet in the pathogenesis of rosacea.","authors":"Yuming Xie, Yue Hu, Junke Huang, Juan Liu, Qing Zhang","doi":"10.11817/j.issn.1672-7347.2025.240075","DOIUrl":"https://doi.org/10.11817/j.issn.1672-7347.2025.240075","url":null,"abstract":"<p><p>Rosacea is a common chronic inflammatory skin disease that predominantly affects the central face. It can impair appearance and cause various discomforts, thus negatively impacting patients' physical and mental well-being as well as their quality of life. Its pathophysiological mechanisms involve multiple factors. Studies have confirmed that ultraviolet radiation plays a significant role in the pathogenesis of rosacea, affecting skin tissues, cells, DNA, and proteins, and inducing oxidative damage. Ultraviolet can lead to the occurrence and development of rosacea by up-regulating the expression of LL-37, matrix metalloproteinase, vascular endothelial growth factor, and reactive oxygen species, and influence their interactions, thereby triggering inflammatory responses, altering the dermal matrix, and promoting capillary dilation and neovascularization, which contribute to the onset and progression of rosacea. Exploring the role of ultraviolet in the pathogenesis of rosacea can provide new strategies for protection and treatment, and enhance awareness of ultraviolet protection among patients with rosacea.</p>","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"50 3","pages":"396-401"},"PeriodicalIF":0.0,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中南大学学报(医学版)Pub Date : 2025-03-28DOI: 10.11817/j.issn.1672-7347.2025.240537
Yuchun Yang, Xiaojie Zhang, Ti Chen
{"title":"Research progress in the role of gut microbiota in ethanol metabolism.","authors":"Yuchun Yang, Xiaojie Zhang, Ti Chen","doi":"10.11817/j.issn.1672-7347.2025.240537","DOIUrl":"https://doi.org/10.11817/j.issn.1672-7347.2025.240537","url":null,"abstract":"<p><p>In recent years, gut microbiota has been increasingly recognized as a key player in ethanol metabolism and the development of related diseases. On one hand, ethanol intake directly affects the gut, leading to significant alterations in microbial diversity and composition. On the other hand, gut microbiota influences ethanol-induced damage to various organs, especially the liver, through multiple metabolic byproducts (such as short-chain fatty acids like butyrate, propionate, and acetate), modulation of immune responses, alteration of intestinal barrier function, and regulation of ethanol-metabolizing enzymes. Given the close association between gut microbiota and ethanol metabolism, the gut microbiome presents a promising therapeutic target for alcohol-related liver diseases. This review summarizes recent advances in understanding how gut microbiota affects ethanol metabolism, aiming to elucidate its role in the onset and progression of ethanol-related diseases and to provide a theoretical basis and novel targets for microbiota-based interventions.</p>","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"50 3","pages":"501-510"},"PeriodicalIF":0.0,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中南大学学报(医学版)Pub Date : 2025-03-28DOI: 10.11817/j.issn.1672-7347.2025.240250
Yang Liao, Daomiao Xu, Li Li
{"title":"A case of mitochondrial encephalomyopathy remarkable presenting with refractory shock.","authors":"Yang Liao, Daomiao Xu, Li Li","doi":"10.11817/j.issn.1672-7347.2025.240250","DOIUrl":"10.11817/j.issn.1672-7347.2025.240250","url":null,"abstract":"<p><p>Mitochondrial encephalomyopathy is a multisystemic metabolic disorder caused by mutations in mitochondrial or nuclear genes. It commonly presents with stroke-like episodes or myopathy as initial symptoms. This paper reports a young male patient with mitochondrial encephalomyopathy whose early and prominent clinical manifestation was refractory shock, without typical neurological symptoms. The patient initially presented with abdominal pain and lower limb weakness, followed by severe hypotension requiring high-dose vasopressors to maintain blood pressure. His lactate level peaked at 20 mmol/L. After 10 days of symptomatic and supportive treatment, his hypotension resolved; lactate levels returned to normal by day 22. One month later, he still had difficulty weaning from mechanical ventilation and exhibited persistent limb weakness. Genetic testing of the biceps brachii revealed an m.3271T>C mutation in the mitochondrial tRNA gene. Mitochondrial encephalomyopathy may initially present with severe circulatory dysfunction. In patients with lactic acidosis not related to hypoperfusion, mitochondrial disease should be considered, and genetic testing of muscle or other peripheral tissues may improve diagnostic yield.</p>","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"50 3","pages":"511-516"},"PeriodicalIF":0.0,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中南大学学报(医学版)Pub Date : 2025-03-28DOI: 10.11817/j.issn.1672-7347.2025.240531
Xiangli Yin, Quan Zhu, Ji Li, Yizhou Zou, Qizhi Luo
{"title":"Association of <i>MICA</i> gene polymorphisms and SNP loci with susceptibility to rosacea.","authors":"Xiangli Yin, Quan Zhu, Ji Li, Yizhou Zou, Qizhi Luo","doi":"10.11817/j.issn.1672-7347.2025.240531","DOIUrl":"https://doi.org/10.11817/j.issn.1672-7347.2025.240531","url":null,"abstract":"<p><strong>Objectives: </strong>The major histocompatibility complex class I chain-related gene A (<i>MICA</i>), a component of the human leukocyte antigen (<i>HLA</i>) gene complex, is involved in the pathogenesis of various diseases including cancers and autoimmune disorders. Rosacea, a chronic inflammatory skin disease with a complex pathogenesis, potentially influenced by genetic and autoimmune factors. This study aims to investigate the relationship among <i>MICA</i> gene polymorphisms, single nucleotide polymorphisms (SNPs), and susceptibility to rosacea, thereby offering new insights into the disease mechanism.</p><p><strong>Methods: </strong>Peripheral blood DNA samples were collected from 84 patients with rosacea (rosacea group) and 223 healthy volunteers (control group) who visited the Dermatology Outpatient Department of Xiangya Hospital of Central South University between November 2017 and November 2019. <i>MICA</i> genotyping was performed using polymerase chain reaction-sequencing-based typing (PCR-SBT) and the next-generation sequencing (NGS), and the accuracy of the 2 methods was compared. The frequency distributions of <i>MICA</i> alleles between the 2 groups were analyzed. Amino acid clustering and SNP site analyses were conducted to identify haplotype-linked SNPs and to classify MICA polymorphic variants. Distribution differences of these classifications between groups were also examined.</p><p><strong>Results: </strong>Blood tests in rosacea patients showed mildly elevated, with no significant changes in lymphocyte counts. Both PCR-SBT and NGS accurately identified <i>MICA</i> alleles. The most common alleles in the rosacea group were <i>MICA*010:01</i>, <i>MICA*008:04</i>, and <i>MICA*019:01</i>. The frequencies of <i>MICA*002:01</i> and <i>MICA*027</i> were significantly lower in the rosacea group compared to controls (6.55% vs 18.16% and 1.19% vs 5.38%, respectively), while and <i>MICA*010:01</i> were significantly higher (7.74% vs 3.36% and 31.55% vs 18.61%, respectively; all <i>P</i><0.05). Five short tandem repeat (STR) alleles were identified. Frequencies of <i>MICA-A4</i> and <i>MICA-A9</i> were lower in the rosacea group than in the control group (16.07% vs 23.32% and 7.74% vs 17.26%, respectively), whereas <i>MICA-A6</i> was higher (10.12% vs 4.03%; all <i>P</i><0.05). Clustering and SNP analysis identified 6 linked SNP sites, classifying MICA variants into Type I (C<sub>36</sub>+M<sub>129</sub>+K<sub>173</sub>+G<sub>206</sub>+W<sub>210</sub>+S<sub>215</sub>) and Type II (Y<sub>36</sub>+V<sub>129</sub>+E<sub>173</sub>+S<sub>206</sub>+R<sub>210</sub>+T<sub>215</sub>). Type I MICA variants were significantly associated with rosacea susceptibility.</p><p><strong>Conclusions: </strong><i>MICA</i> gene polymorphisms are associated with susceptibility to rosacea, and there are 6 linked SNP sites within the <i>MICA</i> gene. Based on this, MICA polymorphic variants are classified into Type I and Type II, with Type I being m","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"50 3","pages":"319-330"},"PeriodicalIF":0.0,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Causal relationship between gut microbiota and diabetes based on Mendelian randomization.","authors":"Manjun Luo, Ziye Li, Mengting Sun, Jiapeng Tang, Tingting Wang, Jiabi Qin","doi":"10.11817/j.issn.1672-7347.2025.240555","DOIUrl":"https://doi.org/10.11817/j.issn.1672-7347.2025.240555","url":null,"abstract":"<p><strong>Objectives: </strong>The gut microbiota plays a crucial role in the pathophysiology of various types of diabetes. However, the causal relationship between them has yet to be systematically elucidated. This study aims to explore the potential causal associations between gut microbiota and diabetes using a two-sample Mendelian randomization (MR) analysis, based on multiple taxonomic levels.</p><p><strong>Methods: </strong>Eligible instrumental variables were extracted from the selected genome-wide association study (GWAS) data on gut microbiota. These were combined with GWAS datasets on type 1 diabetes (T1D), type 2 diabetes (T2D), and gestational diabetes mellitus (GDM) to conduct forward MR analysis, sensitivity analysis, reverse MR analysis, and validation of significant estimates. Microbial taxa with causal effects on T1D, T2D, and GDM were identified based on a comprehensive assessment of all analytical stages.</p><p><strong>Results: </strong>A total of 2 179, 2 176, and 2 166 single nucleotide polymorphisms (SNP) were included in the MR analyses for gut microbiota with T1D, T2D, and GDM, respectively. MR results indicated causal associations between: Six microbial taxa (<i>Eggerthella</i>, <i>Lachnospira</i>, Bacillales, Desulfovibrionales, <i>Parasutterella</i>, and <i>Turicibacter</i>) and T1D; 9 microbial taxa (Verrucomicrobia, Deltaproteobacteria, Actinomycetales, Desulfovibrionale, Actinomycetaceae, Desulfovibrionaceae, <i>Actinomyces</i>, Alcaligenaceae, and <i>Lachnospiraceae NC2004 group</i>) and T2D; 10 microbial taxa (Betaproteobacteria, <i>Coprobacter</i>, <i>Ruminococcus2</i>, Tenericutes, Clostridia, Methanobacteria, Mollicutes, Methanobacteriales, Methanobacteriaceae, and <i>Methanobrevibacter</i>) and GDM.</p><p><strong>Conclusions: </strong>This study identified specific gut microbial taxa that may significantly increase or decrease the risk of developing diabetes. Some findings were fully replicated in independent validation datasets. However, the underlying biological mechanisms of these causal relationships warrant further investigation through mechanistic studies and population-based research.</p>","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"50 3","pages":"469-481"},"PeriodicalIF":0.0,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中南大学学报(医学版)Pub Date : 2025-03-28DOI: 10.11817/j.issn.1672-7347.2025.240222
Ling Jiang, Yibo Hu, Jing Chen
{"title":"N<sup>6</sup>-methyladenosine modification and skin diseases.","authors":"Ling Jiang, Yibo Hu, Jing Chen","doi":"10.11817/j.issn.1672-7347.2025.240222","DOIUrl":"https://doi.org/10.11817/j.issn.1672-7347.2025.240222","url":null,"abstract":"<p><p>Currently, research on N<sup>6</sup>-methyladenine (m<sup>6</sup>A) is extensive in the field of oncology, while studies involving m<sup>6</sup>A and skin diseases remain relatively limited. Based on existing reports, we searched PubMed and Web of Science for literature related to m<sup>6</sup>A and dermatological conditions. Analysis of citation counts and journal impact factors revealed a significant upward trend in the volume of m<sup>6</sup>A-related research. Term frequency analysis of titles and abstracts indicated that studies mainly focus on skin tumors and inflammatory or immune-related skin diseases, particularly melanoma, psoriasis, and skin development. Transcriptomic data from the Gene Expression Omnibus (GEO) were analyzed, revealing differential expression of m<sup>6</sup>A-related genes in 4 types of skin tumors (including squamous cell carcinoma and basal cell carcinoma) as well as in inflammatory skin diseases such as psoriasis and atopic dermatitis, and potential mechanisms of action were also explored. Findings suggest that m<sup>6</sup>A modifications exhibit heterogeneity between neoplastic and non-neoplastic skin diseases. However, the regulatory mechanisms of m<sup>6</sup>A dynamic modifications on key genes involved in dermatological disorders remain unclear and warrant further investigation.</p>","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"50 3","pages":"382-395"},"PeriodicalIF":0.0,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中南大学学报(医学版)Pub Date : 2025-02-28DOI: 10.11817/j.issn.1672-7347.2025.240044
Shengjin Wang, Feng Sun, Xinghong Wang
{"title":"Domestic research on extra-gastrointestinal stromal tumors: A ten-year review.","authors":"Shengjin Wang, Feng Sun, Xinghong Wang","doi":"10.11817/j.issn.1672-7347.2025.240044","DOIUrl":"https://doi.org/10.11817/j.issn.1672-7347.2025.240044","url":null,"abstract":"<p><strong>Objectives: </strong>There is currently no consensus on whether extra-gastrointestinal stromal tumors (EGISTs) and gastrointestinal stromal tumors (GISTs) are the same type of tumor, and whether the diagnosis and treatment of EGISTs can directly replicate the current diagnostic and treatment standards for GISTs. This study aims to further elucidate the clinical and pathological characteristics, diagnosis, treatment, and prognosis of EGISTs by analyzing the research results of domestic scholars in the field of EGISTs in the past decade.</p><p><strong>Methods: </strong>A review was conducted on original Chinese and English research articles published from 2013 to 2022 focusing on EGISTs. A descriptive approach was used to extract key information from the literature, including patient demographics, tumor location, tumor diameter, mitotic figures, risk stratification, immunohistochemical markers, cell type, and prognostic factors. The data were subjected to statistical analysis.</p><p><strong>Results: </strong>A total of 12 articles containing 780 EGIST patients were included. The male-to-female incidence of EGISTs was 0.92꞉1. The most common sites of EGISTs were mesentery (30.96%), peritoneum or retroperitoneum (28.53%), omentum (20.32%), and pelvic cavity (12.52%). 52.77% of EGISTs had tumor diameters greater than 10 cm, and the proportions of EGISTs with nuclear fission patterns greater than 5/50 high power field (HPF) and greater than 10/50 HPF were 51.24% and 26.11%, respectively. The proportion of high-risk EGISTs was 79.05%. The positive rates of immune markers CD117, CD34, and DOG-1 in EGISTs were 82.3%, 69.0%, and 79.5%, respectively. The proportion of Ki-67 >5% was 49.2%, and the proportion of Ki-67 >10% was 24.8%. The proportions of EGISTs in spindle cells, epithelial cells, and mixed cells were 74.4%, 14.8%, and 13.1%, respectively. The diameter of the tumor, resection method, risk level, Ki-67 index, mitotic counts, presence of rupture/bleeding/necrosis/peripheral tissue invasion/recurrence and metastasis, as well as the use of imatinib treatment after surgery were important factors affecting the prognosis of EGISTs.</p><p><strong>Conclusions: </strong>Current medical research is relatively well cognizant of GISTs with primary sites in the gastrointestinal tract. Compared with GISTs, EGISTs have large tumor diameters, high mitotic counts, a high percentage of high-risk grades, relatively unique molecular expression, and high aggressiveness. EGISTs differ from GISTs in clinicopathological characteristics. Whether EGISTs and GISTs share a common origin remains unclear. If they are distinct tumor entities, separate diagnostic and treatment guidelines for EGISTs should be established. If EGISTs are ultimately confirmed to be a special subtype of GISTs, then directly applying existing GIST-based standards to EGISTs may be inappropriate. A more scientific approach would involve subclassifying EGISTs based on anatomical location and ","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"50 2","pages":"237-250"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144310436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中南大学学报(医学版)Pub Date : 2025-02-28DOI: 10.11817/j.issn.1672-7347.2025.240524
Yi Zhu, Junhui Li, Min Yang, Pengpeng Zhang, Cai Li, Hong Liu
{"title":"Kazinol B alleviates hypoxia/reoxygenation-induced hepatocyte injury by inhibiting the JNK signaling pathway.","authors":"Yi Zhu, Junhui Li, Min Yang, Pengpeng Zhang, Cai Li, Hong Liu","doi":"10.11817/j.issn.1672-7347.2025.240524","DOIUrl":"https://doi.org/10.11817/j.issn.1672-7347.2025.240524","url":null,"abstract":"<p><strong>Objectives: </strong>Hypoxia/reoxygenation (H/R) injury is a critical pathological process during liver transplantation. Kazinol B has known anti-inflammatory, anti-apoptotic, and metabolic regulatory properties, but its protective mechanism in H/R-induced liver injury remains unclear. This study aims to investigate the protective effects and underlying mechanisms of Kazinol B in H/R-induced hepatocyte injury.</p><p><strong>Methods: </strong>An ischemia-reperfusion model was established in healthy adult male Sprague-Dawley rats, and an in vitro H/R model was created using cultured hepatocytes. Hepatocytes were treated with Kazinol B (0-100 μmol/L) to assess cytotoxicity and protective effects. Cell viability was evaluated using the cell counting kit-8 (CCK-8) and lactate dehydrogenase (LDH) release assays. Expression of apoptosis-related proteins, B-cell lymphoma 2 (Bcl-2), Bcl-2-associated death promoter (Bad), and cleaved caspase-3, was detected by Western blotting. Reactive oxygen species (ROS) levels were assessed via fluorescence probes, and inflammatory cytokines tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were measured using enzyme-linked immunosorbent assay (ELISA). TdT-mediated nick end labeling (TUNEL) staining was performed to assess DNA damage and apoptosis.</p><p><strong>Results: </strong>Kazinol B had no significant effect on hepatocyte viability at 0-50 μmol/L, but showed cytotoxicity at 100 μmol/L (<i>P</i><0.05). At 0.1-20 μmol/L, Kazinol B significantly improved cell survival, reduced LDH release, decreased apoptosis, and attenuated DNA damage (all <i>P</i><0.001). At 10 μmol/L, Kazinol B markedly down-regulated Bad and cleaved caspase-3 (both <i>P</i><0.05), and up-regulated Bcl-2 (<i>P</i><0.01). It also dose-dependently reduced ROS levels and inflammatory cytokines TNF-α and IL-1β (all <i>P</i><0.01). Both in vitro and in vivo, Kazinol B inhibited activation of the c-Jun N-terminal kinase (JNK) pathway without affecting extracellular regulated protein kinase (ERK) signaling (<i>P</i>>0.05). TUNEL staining showed that the protective effect of Kazinol B against apoptosis was partially reversed by the JNK agonist anisomycin (<i>P</i><0.01).</p><p><strong>Conclusions: </strong>Kazinol B mitigates hepatocyte injury induced by H/R by inhibiting the JNK signaling pathway. Its protective effect is associated with suppression of oxidative stress and inflammation, indicating its potential as a hepatoprotective agent.</p>","PeriodicalId":39801,"journal":{"name":"中南大学学报(医学版)","volume":"50 2","pages":"181-189"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144310441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}